Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Wolter

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
American Journal of Respiratory and Critical Care Medicine|August 27, 2020
Not Quite the Bully in the Schoolyard: <i>Staphylococcus aureus</i> Can Survive and Coexist with <i>Pseudomonas aeruginosa</i> in the Cystic Fibrosis LungDaniel J Wolter, Bonnie W Ramsey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2005
Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosaPhilip D Lister, Daniel J Wolter
Cell Host & Microbe|October 10, 2014
Strength in diversityDaniel J Wolter, Lucas R Hoffman
American Journal of Respiratory and Critical Care Medicine|March 24, 2025
Sticky Staph: A New Story About Mucoidy and Cystic FibrosisDaniel J Wolter, Lucas R Hoffman
Current Pharmaceutical Design|August 17, 2012
Mechanisms of β-lactam resistance among Pseudomonas aeruginosaDaniel J Wolter, Philip D Lister
Antimicrobial Agents and Chemotherapy|October 28, 2005
AmpC and OprD are not involved in the mechanism of imipenem hypersusceptibility among Pseudomonas aeruginosa isolates overexpressing the mexCD-oprJ efflux pumpDaniel J Wolter, Nancy D Hanson, Philip D Lister
FEMS Microbiology Letters|June 24, 2004
Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistanceDaniel J Wolter, Nancy D Hanson, Philip D Lister
Clinical Microbiology Reviews|October 14, 2009
Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanismsPhilip D Lister, Daniel J Wolter, Nancy D Hanson
Journal of Clinical Microbiology|August 1, 2008
Isolation and characterization of an epidemic methicillin-resistant Staphylococcus aureus 15 variant in the central United StatesDaniel J Wolter, Archana Chatterjee, Meera Varman, et al.
The Journal of Antimicrobial Chemotherapy|May 27, 2009
Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotypeDaniel J Wolter, Jennifer A Black, Philip D Lister, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
American Journal of Respiratory and Critical Care Medicine|August 27, 2020
Not Quite the Bully in the Schoolyard: <i>Staphylococcus aureus</i> Can Survive and Coexist with <i>Pseudomonas aeruginosa</i> in the Cystic Fibrosis LungDaniel J Wolter, Bonnie W Ramsey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2005
Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosaPhilip D Lister, Daniel J Wolter
Cell Host & Microbe|October 10, 2014
Strength in diversityDaniel J Wolter, Lucas R Hoffman
American Journal of Respiratory and Critical Care Medicine|March 24, 2025
Sticky Staph: A New Story About Mucoidy and Cystic FibrosisDaniel J Wolter, Lucas R Hoffman
Current Pharmaceutical Design|August 17, 2012
Mechanisms of β-lactam resistance among Pseudomonas aeruginosaDaniel J Wolter, Philip D Lister
Antimicrobial Agents and Chemotherapy|October 28, 2005
AmpC and OprD are not involved in the mechanism of imipenem hypersusceptibility among Pseudomonas aeruginosa isolates overexpressing the mexCD-oprJ efflux pumpDaniel J Wolter, Nancy D Hanson, Philip D Lister
FEMS Microbiology Letters|June 24, 2004
Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistanceDaniel J Wolter, Nancy D Hanson, Philip D Lister
Clinical Microbiology Reviews|October 14, 2009
Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanismsPhilip D Lister, Daniel J Wolter, Nancy D Hanson
Journal of Clinical Microbiology|August 1, 2008
Isolation and characterization of an epidemic methicillin-resistant Staphylococcus aureus 15 variant in the central United StatesDaniel J Wolter, Archana Chatterjee, Meera Varman, et al.
The Journal of Antimicrobial Chemotherapy|May 27, 2009
Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotypeDaniel J Wolter, Jennifer A Black, Philip D Lister, et al.
Pageof 4